News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Northx Biologics AB Commences Operations at Matfors Facility's New Innovation Hub
Friday, September 29, 2023NorthX Biologics AB is excited to announce the official opening of its advanced Innovation Hub located at the Matfors facility
Immunogenesis Initiates Phase 1a/1b Clinical Trial for IMGS-001 in Patients With Advanced Solid Tumors Who Have Relapsed or Are Refractory
Friday, September 29, 2023ImmunoGenesis has recently announced the initiation of its Phase ab clinical trial for its lead candidate IMGS at The University of Texas MD Anderson Cancer Center in Houston Texas
Merck KGaA, Darmstadt, Germany and Quris-ai Enhance Their Collaboration
Friday, September 29, 2023QurisAI an innovative player in the pharmaceutical industry powered by artificial intelligence AI has announced the expansion of its collaboration with Merck KGaA Darmstadt Germany a prominent science and technology company
GenSight Biologics Issues Update Regarding Scientific Advice from the European Medicines Agency for LUMEVOQ®
Thursday, September 28, 2023GenSight Biologics Euronext SIGHT ISIN FR PEAPME eligible has provided an update regarding its discussions with the European Medicines Agency EMA on the design of a new Phase III trial for LUMEVOQ
Pathios Therapeutics Granted Funding by Innovate UK to Assess Novel Immunotherapy Approach in Malignant Brain Cancer Models
Thursday, September 28, 2023Pathios Therapeutics Limited a biotechnology company dedicated to advancing innovative cancer therapies has been awarded a grant of equivalent to approximately US from Innovate UK
Commencement of Immunotherapy Dosing for Leukemia Patients in Phase I/II Trial of ProTcell Therapy SMART101 in ReSET-02
Thursday, September 28, 2023Smart Immune a clinicalstage biotechnology company focusing on the development of ProTcell a Tcell progenitor therapy platform designed to swiftly rejuvenate the immune system has officially initiated its ReSET Phase III trial for adult acute leukemi...
FDA Approves Chrysalis for Clinical Trials of Chrysalin™ (TP508)
Wednesday, September 27, 2023Chrysalis BioTherapeutics Inc made an announcement today regarding the approval from the US Food and Drug Administration FDA to commence human clinical trials aimed at treating acute lung failure
Novo Nordisk and Evotec Collaborate to Introduce LAB eN², a Translational Drug Discovery Accelerator Targeting Innovation Gaps in Cardiometabolic Diseases
Wednesday, September 27, 2023Novo Nordisk and Evotec SE have introduced LAB eN a novel program designed to accelerate earlystage research originating from academic institutions with a primary focus on addressing unmet needs in cardiometabolic diseases rare blood disorders and ra...
Senores Pharmaceuticals, Inc. Introduces Nicardipine Hydrochloride Capsules USP, Available in 20 Mg and 30 Mg, to the U.S. Market.
Tuesday, September 26, 2023Senores Pharmaceuticals Inc has recently introduced Nicardipine Hydrochloride Capsules USP in mg and mg strengths to the US market
Pierre Fabre and Vernalis Laboratories Announce Collaboration in Oncology Drug Research and Development
Tuesday, September 26, 2023Laboratoires Pierre Fabre and Vernalis RD Ltd a whollyowned subsidiary of HitGen Inc are excited to announce a longterm collaboration aimed at the discovery of preclinical candidates for a variety of oncological targets
